Frontiers in Oncology | Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Original Research

Accepted on 26 Mar 2025

Comparative Efficacy of Interventional Therapy with or without Targeted Immunotherapy in Child-Pugh B Hepatocellular Carcinoma Patients: a singlecenter, retrospective study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Xuwei Guo
Man Zhao
Xiao-Ling Duan
Guangjie Han
Wang Jinfeng
Jianfei Shi
Xin Han
Guang Yang
Fei Yin

Frontiers in Oncology

doi 10.3389/fonc.2025.1541805

Systematic Review

Published on 26 Mar 2025

Efficacy of repeat hepatectomy versus radiofrequency ablation for recurrent hepatocellular carcinoma: a Systematic Review and meta-analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Qingchen Meng
Xiaohang Li
Hongxin Lang

Frontiers in Oncology

doi 10.3389/fonc.2025.1559491

170 views

Original Research

Accepted on 25 Mar 2025

Longitudinal Study of factors associated with the anti-cancer efficacy and liver function in HCC patients treated with TACE in combination with Percutaneous Ablation

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Huhu Ren
Jian Chen
Zhiqun Wu
Chen Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1566865

Case Report

Published on 25 Mar 2025

Case Report: Laparoscopic resection of a tumor in the right posterior lobe of the liver in a patient with situs inversus totalis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Bin Yang
Xin Luo
Genjun Mao

Frontiers in Oncology

doi 10.3389/fonc.2025.1513584

339 views

Original Research

Published on 25 Mar 2025

Evaluation of PDZD11 in hepatocellular carcinoma: prognostic value and diagnostic potential in combination with AFP

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yiyun Ni
Bin Liu
Weizhen Zhang
Yilin Pang
Yaling Tian
Qingsong Lv
Shengwen Shi
Yang Zheng
Huihui Fan

Frontiers in Oncology

doi 10.3389/fonc.2025.1533865

414 views

Case Report

Published on 25 Mar 2025

Lenvatinib-induced pemphigus erythematosus in hepatocellular carcinoma: a unique case report

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Xiaoqing Li
Suhua Ma
Qing She
Zirong Liu
Yanan Liu
Yanjing Kuang
Xiaozhun Huang
Zhengyin Zhan

Frontiers in Oncology

doi 10.3389/fonc.2025.1505596

407 views

Original Research

Accepted on 24 Mar 2025

Prognostic Role of Inflammatory and Tumor Biomarkers in Hilar Cholangiocarcinoma Patients

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Di Zeng
SAUD AHMAD SAAD
Zhen You
NANSHENG Cheng

Frontiers in Oncology

doi 10.3389/fonc.2025.1555369

Original Research

Published on 20 Mar 2025

PSMD11 and PSMD14 may serve as novel biomarkers for the prognosis of pancreatic ductal adenocarcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yan-Hui Yang
Zhe-Hua Xing
Hao Wang
Chi Zhang
Yu-Bo Liu
Qian-Qian Bai
Fang-Fei Liu
Wei-Feng Liu
Jun-Chuan Yang
Da-Huan Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1555649

309 views

Case Report

Published on 18 Mar 2025

Case Report: Long lasting response with TKI for combined hepatocellular-cholangiocarcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Chiara Deiana
Andrea Palloni
Mirta Mosca
Francesco Vasuri
Stefano Chillotti
Simona Tavolari
Dario De Biase
Giorgio Frega
Elisa Giovannetti
Giovanni Brandi

Frontiers in Oncology

doi 10.3389/fonc.2025.1459705

360 views

Original Research

Published on 17 Mar 2025

A combined radiomics and clinical model for preoperative differentiation of intrahepatic cholangiocarcinoma and intrahepatic bile duct stones with cholangitis: a machine learning approach

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Hongwei Qian
Yanhua Huang
Yuxing Dong
Luohang Xu
Ruanchang Chen
Fangzheng Zhou
Difan Zhou
Jianhua Yu
Baochun Lu

Frontiers in Oncology

doi 10.3389/fonc.2025.1546940

378 views

Original Research

Published on 13 Mar 2025

A nomogram based on quantitative MR signal intensity predicts early response to combined systemic treatment in patients with hepatocellular carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Ran Tao
Haohao Lu
Xiangjun Dong
Qian Qian Ren
Hongjie Fan
Zhaoming Tang
Xiangwen Xia

Frontiers in Oncology

doi 10.3389/fonc.2025.1527108

400 views

Systematic Review

Published on 11 Mar 2025

A systematic review and meta-analysis of the comparison of laparoscopic radiofrequency ablation to percutaneous radiofrequency ablation for hepatocellular carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Ya-Qiong Wang
Zhen-Kun Tan
Zha Peng
Hai Huang

Frontiers in Oncology

doi 10.3389/fonc.2025.1559343

380 views

Original Research

Published on 11 Mar 2025

Histogram analysis of multiple mathematical diffusion-weighted imaging models for preoperative prediction of Ki-67 expression in hepatocellular carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Hongxiang Li
Jing Zhang
Baoer Liu
Zeyu Zheng
Yikai Xu

Frontiers in Oncology

doi 10.3389/fonc.2025.1531236

324 views

Original Research

Accepted on 10 Mar 2025

Metabolic syndrome is associated with worse prognosis in elderly patients with hepatocellular carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Junwei Huang
Yiming Tao
Jianguo Yao
Xiaorui Song
Yiming Li
Yiting Yuan

Frontiers in Oncology

doi 10.3389/fonc.2025.1542328

Original Research

Published on 07 Mar 2025

GINS1 is a prognostic biomarker and correlated with methylation and immune escape in liver hepatocellular carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Mingchao Liang
Tianqi Lai
Zhen Li
Wei Yu
Mingrong Cao
Nan Yao
Youzhu Hu
Tongzheng Liu
Junjie Liang

Frontiers in Oncology

doi 10.3389/fonc.2025.1492599

641 views

Original Research

Published on 07 Mar 2025

TM4SF1 overexpression in tumor-associated endothelial cells promotes microvascular invasion in hepatocellular carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Junwu Guo
Liangrui Chen
Binghua Dai
Chengjun Sui
Zhitao Dong
Keji Chen
Kecai Duan
Kunpeng Fang
Aijun Li
Kui Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1526177

754 views